ERBB2 and breast carcinoma: While it is unclear how this Nrg1/ErbB2 axis mediates metabolic remodelling, it could be through the modulation of fatty acid metabolism as transient overexpression of ErbB2 in a breast cancer cell line promoted glycolysis and cell migration by upregulating fatty acid synthase involved in neoplastic lipogenesis [48,49].